FORT MYERS, Fla., March 21 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. today announced that it has engaged Hawk Associates as its investor relations provider.
Robert Gasparini, President of NeoGenomics, said, “Frank Hawkins, Julie Marshall and their highly respected team at Hawk have a strong track record of helping small-cap companies successfully communicate their stories to the financial and investor marketplace. Their proactive and strategic approach together with their state-of-the-art technology and techniques are ideal for NeoGenomics at this time in our development. We have an important and evolving story that is not well known outside of a limited group. We expect the Hawk team to be able to help us effectively communicate our progress and the directions we are headed.”
Frank Hawkins, CEO of Hawk Associates, said, “NeoGenomics is at an exciting point in its history. It has demonstrated the power of its business model by expanding into 16 states just over the last year alone. Given the explosion in the use of genetic tests to help diagnose cancer and NeoGenomics’ extraordinary customer service and turn-around times, we believe NeoGenomics is extremely well-positioned in this rapidly growing and highly profitable market segment. In addition, as the only publicly traded pure play company focused on genetic and molecular testing services, we believe NeoGenomics offers investors a compelling value proposition. We look forward to keeping Wall Street informed about the company’s progress.”
Information for investors, including a profile of NeoGenomics and the ability to sign up for free NeoGenomics email alert notifications, may be found at http://www.americanmicrocaps.com .
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that offers cancer genetic diagnostic testing services, including cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry and molecular genetic testing. NeoGenomics is headquartered in Fort Myers, FL and services the needs of oncologists, pathologists, urologists, hospitals, and other reference laboratories not offering genetic testing throughout the United States. For additional information about NeoGenomics, please visit our website at http://www.neogenomics.org . An investment profile about NeoGenomics may be found at http://www.americanmicrocaps.com/ngnm/profile.pdf .
About Hawk Associates, Inc.
Hawk Associates, Inc. is a full-service national investor relations and financial media relations consulting firm serving clients nationwide and in Canada. For more information and a company profile, visit http://www.hawkassociates.com or contact Frank Hawkins or Julie Marshall at (305) 451-1888 or info@hawkassociates.com .
Forward-Looking Statements
Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward-looking statements, including, but not limited to, the Company incurring significant losses since its inception and experiencing negative operating margins and negative cash flows from operations; any adverse effect or limitations caused by governmental regulations; and the company’s ability to attract and retain qualified personnel, to initiate and develop client relationships and to gain market acceptance of service offerings, as well as other risks described from time to time in the company’s filings with the Securities and Exchange Commission. Although the Company has used its best efforts to be accurate in making those forward-looking statements, there can be no assurance that the assumptions made by management will materialize. In addition, the information set forth in the Company’s Form 10-KSB for the fiscal year ended December 31, 2004, and the soon to be filed Form 10-KSB for the fiscal year ended December 31, 2005 describe certain additional risks and uncertainties that could cause actual results to vary materially from the future results covered in such forward-looking statements. The Company undertakes no obligation to publicly revise or update the forward-looking statements to reflect new information, subsequent events or otherwise.
NeoGenomics, Inc.
CONTACT: Steven Jones, NeoGenomics, Inc., +1-239-598-0964, orsjones@neogenomics.org; or Frank N. Hawkins, Jr. or Julie Marshall, both ofHawk Associates, Inc., +1-305-451-1888, or info@hawkassociates.com, forNeoGenomics